Go-Dact: A Phase 3b Randomized Double-Blind Placebo-Controled Proof-Of-Concept Trial, of Golimumab Plus Methotrexate (MTX) versus MTX Monotherapy, in Improving Dactylitis, in MTX Naive Psoriatic Arthritis Patients-MedSci.cn

Go-Dact: A Phase 3b Randomized Double-Blind Placebo-Controled Proof-Of-Concept Trial, of Golimumab Plus Methotrexate (MTX) versus MTX Monotherapy, in Improving Dactylitis, in MTX Naive Psoriatic Arthritis Patients

Vieira-Sousa, E; Alves, P; Rodrigues, AM; Teixeira, F; Tavares-Costa, J; Bernardo, A; Pimenta, S; Pimentel-Santos, F; Gomes, JL; Aguiar, R; Pinto, P; Videira, T; Catita, C; Santos, H; Borges, J; Sequeira, G; Ribeiro, C; Teixeira, L; Avila-Ribeiro, P;

ARTHRITIS & RHEUMATOLOGY, 2019; 71 ():

科室
- - 订阅+
  - 更多科室
工具
服务